Smith & Nephew PLC ADR (SNN): Price and Financial Metrics
SNN Price/Volume Stats
Current price | $23.75 | 52-week high | $33.08 |
Prev. close | $24.05 | 52-week low | $21.85 |
Day low | $23.58 | Volume | 746,600 |
Day high | $23.90 | Avg. volume | 852,742 |
50-day MA | $27.16 | Dividend yield | 3.64% |
200-day MA | $28.96 | Market Cap | 10.37B |
SNN Stock Price Chart Interactive Chart >
SNN POWR Grades
- SNN scores best on the Stability dimension, with a Stability rank ahead of 84.88% of US stocks.
- The strongest trend for SNN is in Momentum, which has been heading down over the past 177 days.
- SNN's current lowest rank is in the Momentum metric (where it is better than 23.9% of US stocks).
SNN Stock Summary
- SNN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2,195.85 -- higher than 98.52% of US-listed equities with positive expected earnings growth.
- With a price/earnings ratio of 49.9, SMITH & NEPHEW PLC P/E ratio is greater than that of about 88.65% of stocks in our set with positive earnings.
- In terms of volatility of its share price, SNN is more volatile than merely 13.01% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to SMITH & NEPHEW PLC are MG, CCJ, WAT, SFM, and PNR.
- Visit SNN's SEC page to see the company's official filings. To visit the company's web site, go to www.smith-nephew.com.
SNN Valuation Summary
- SNN's price/earnings ratio is 49.9; this is 86.89% higher than that of the median Healthcare stock.
- SNN's price/sales ratio has moved up 0.8 over the prior 243 months.
Below are key valuation metrics over time for SNN.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SNN | 2023-09-22 | 2.1 | 2.1 | 49.9 | 44.4 |
SNN | 2023-09-21 | 2.1 | 2.1 | 50.0 | 44.5 |
SNN | 2023-09-20 | 2.2 | 2.2 | 50.8 | 45.0 |
SNN | 2023-09-19 | 2.2 | 2.2 | 50.9 | 45.1 |
SNN | 2023-09-18 | 2.2 | 2.2 | 51.4 | 45.4 |
SNN | 2023-09-15 | 2.2 | 2.2 | 51.8 | 45.7 |
SNN Growth Metrics
- Its year over year net cashflow from operations growth rate is now at 7.82%.
- Its 5 year net cashflow from operations growth rate is now at 32.37%.
- The year over year net income to common stockholders growth rate now stands at 16.96%.

The table below shows SNN's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 5,215 | 581 | 223 |
2022-06-30 | 5,212 | 1,048 | 524 |
2021-12-31 | 5,212 | 1,048 | 524 |
2021-12-31 | 5,212 | 1,048 | 524 |
2021-06-30 | 4,560.001 | 972.0003 | 448.0001 |
2020-12-31 | 4,560 | 972 | 448 |
SNN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SNN has a Quality Grade of B, ranking ahead of 77.5% of graded US stocks.
- SNN's asset turnover comes in at 0.445 -- ranking 108th of 186 Medical Equipment stocks.
- HOLX, TTOO, and BIOL are the stocks whose asset turnover ratios are most correlated with SNN.
The table below shows SNN's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-03 | 0.445 | 0.694 | 0.050 |
2020-12-31 | 0.449 | 0.694 | 0.051 |
2020-12-31 | 0.449 | 0.694 | 0.051 |
2020-06-27 | 0.556 | 0.740 | 0.146 |
2019-12-31 | 0.592 | 0.740 | 0.174 |
2019-12-31 | 0.592 | 0.740 | 0.174 |
Smith & Nephew PLC ADR (SNN) Company Bio
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. (Source:Wikipedia)
Latest SNN News From Around the Web
Below are the latest news stories about SMITH & NEPHEW PLC that investors may wish to consider to help them evaluate SNN as an investment opportunity.
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
This stock is in the last chance saloon – it needs to start delivering nowThis column broke a few of its own rules when it identified Smith & Nephew, the medical devices company, as a potential post-lockdown turnaround candidate in March 2021 and has only had cause to regret it since. |
Should Value Investors Buy Koninklijke Philips (PHG) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Smith & Nephew (SNN) Loses -5.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerSmith & Nephew (SNN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. |
SNN Price Returns
1-mo | -11.61% |
3-mo | -21.46% |
6-mo | -16.81% |
1-year | 2.70% |
3-year | -36.20% |
5-year | -27.43% |
YTD | -10.21% |
2022 | -20.26% |
2021 | -16.26% |
2020 | -10.45% |
2019 | 30.78% |
2018 | 8.84% |
SNN Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching SNN
Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...